BARCLAYS PLC - CYTOMX THERAPEUTICS INC ownership

CYTOMX THERAPEUTICS INC's ticker is CTMX and the CUSIP is 23284F105. A total of 121 filers reported holding CYTOMX THERAPEUTICS INC in Q4 2019. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
BARCLAYS PLC ownership history of CYTOMX THERAPEUTICS INC
ValueSharesWeighting
Q1 2022$28,000
-95.9%
10,528
-93.3%
0.00%
Q4 2021$682,000
+20.9%
157,460
+42.0%
0.00%
Q3 2021$564,000
-29.7%
110,853
-12.6%
0.00%
Q2 2021$802,000
-24.5%
126,781
-7.7%
0.00%
-100.0%
Q1 2021$1,062,000
+80.3%
137,304
+52.5%
0.00%
Q4 2020$589,000
+199.0%
90,014
+204.7%
0.00%
Q3 2020$197,000
-31.8%
29,540
-14.8%
0.00%
Q2 2020$289,000
+61.5%
34,662
+48.3%
0.00%
Q1 2020$179,000
-60.4%
23,367
-57.0%
0.00%
Q4 2019$452,000
+130.6%
54,293
+104.7%
0.00%
Q3 2019$196,000
-50.6%
26,519
-24.9%
0.00%
Q2 2019$397,000
-8.5%
35,328
-12.5%
0.00%
Q1 2019$434,000
+1569.2%
40,382
+2275.4%
0.00%
Q4 2018$26,000
-91.9%
1,700
-90.2%
0.00%
Q3 2018$321,000
-21.9%
17,322
-3.7%
0.00%
Q2 2018$411,000
-10.1%
17,989
+12.2%
0.00%
Q1 2018$457,000
+3.6%
16,032
-23.2%
0.00%
Q4 2017$441,000
-11.3%
20,870
-23.8%
0.00%
-100.0%
Q3 2017$497,000
+250.0%
27,386
+199.3%
0.00%
Q2 2017$142,000
-35.7%
9,151
-28.6%
0.00%
Q1 2017$221,000
+7266.7%
12,820
+5498.3%
0.00%
Q4 2016$3,000
-40.0%
229
-34.4%
0.00%
Q3 2016$5,000
+66.7%
349
+109.0%
0.00%
Q4 2015$3,0001670.00%
Other shareholders
CYTOMX THERAPEUTICS INC shareholders Q4 2019
NameSharesValueWeighting ↓
Burrage Capital Management LLC 476,110$3,956,0002.65%
MPM BioImpact LLC 855,437$7,109,0002.52%
Exane Asset Management 87,876$730,250,0000.90%
Congress Park Capital LLC 94,661$787,0000.58%
Perceptive Advisors 3,253,923$27,040,0000.54%
BVF INC/IL 766,148$6,367,0000.48%
RTW INVESTMENTS, LP 1,039,593$8,639,0000.33%
EcoR1 Capital, LLC 410,000$3,407,0000.31%
DAFNA Capital Management LLC 100,000$831,0000.28%
HARBOURVEST PARTNERS LLC 79,193$658,0000.27%
View complete list of CYTOMX THERAPEUTICS INC shareholders